Cargando…
Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers
The circulating metabolome provides a snapshot of the physiological state of the organism responding to pathogenic challenges. Here we report alterations in the plasma metabolome reflecting the clinical presentation of COVID-19 patients with mild (ambulatory) diseases, moderate disease (radiological...
Ejemplares similares
-
Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19
por: Silvin, Aymeric, et al.
Publicado: (2020) -
High levels of TNFα in patients with COVID-19 refractory to tocilizumab
por: Danlos, F.X., et al.
Publicado: (2021) -
1694P Discovery of circulating biomarkers in COVID-19 patients undergoing anti-IL6R immunotherapy
por: Michot, J-M., et al.
Publicado: (2020) -
Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis
por: Goubet, Anne-Gaëlle, et al.
Publicado: (2021) -
BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer
por: Rouanne, Mathieu, et al.
Publicado: (2022)